Insider: STAHL NEIL EVP Research and Development - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 56,096 | 0 | 56,096 |
| Value | $31,352,615.36 | $0.00 | $31,352,615.36 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/08/2024 | DDS | 100 | Direct | COM | $1,081.83 | $108,183.00 | 56,096 |
| 08/08/2024 | DDS | 300 | Direct | COM | $1,086.15 | $325,845.00 | 50,999 |
| 08/08/2024 | DDS | 1,006 | Direct | COM | $1,083.76 | $1,090,262.56 | 54,890 |
| 08/08/2024 | DDS | 200 | Direct | COM | $1,082.69 | $216,538.00 | 55,896 |
| 08/08/2024 | DDS | 1,883 | Direct | COM | $1,084.61 | $2,042,320.63 | 53,007 |
| 08/08/2024 | DDS | 1,708 | Direct | COM | $1,085.01 | $1,853,197.08 | 51,299 |
| 02/07/2024 | DDS | 601 | Direct | COM | $949.45 | $570,619.45 | 57,461 |
| 02/07/2024 | DDS | 100 | Direct | COM | $947.34 | $94,734.00 | 59,956 |
| 02/07/2024 | DDS | 3,127 | Direct | COM | $950.43 | $2,971,994.61 | 54,334 |
| 02/07/2024 | DDS | 1,894 | Direct | COM | $948.69 | $1,796,818.86 | 58,062 |
| 02/07/2024 | DDS | 1,237 | Direct | COM | $951.49 | $1,176,993.13 | 53,097 |
| 02/07/2024 | DDS | 1,059 | Direct | COM | $952.49 | $1,008,686.91 | 52,038 |
| 02/07/2024 | DDS | 19 | Direct | COM | $953.00 | $18,107.00 | 52,019 |
| 08/22/2023 | DDS | 782 | Direct | COM | $842.16 | $658,569.12 | 53,100 |
| 08/22/2023 | DDS | 6,309 | Direct | COM | $840.53 | $5,302,903.77 | 58,456 |
| 08/22/2023 | DDS | 4,574 | Direct | COM | $841.41 | $3,848,609.34 | 53,882 |
| 08/05/2022 | DDS | 2,022 | Direct | COM | $611.44 | $1,236,331.68 | 66,070 |
| 08/05/2022 | DDS | 2,076 | Direct | COM | $612.43 | $1,271,404.68 | 63,994 |
| 08/05/2022 | DDS | 3,931 | Direct | COM | $610.49 | $2,399,836.19 | 68,092 |
| 08/05/2022 | DDS | 176 | Direct | COM | $606.78 | $106,793.28 | 76,401 |
| 08/05/2022 | DDS | 3,218 | Direct | COM | $613.49 | $1,974,210.82 | 60,776 |
| 08/05/2022 | DDS | 724 | Direct | COM | $607.47 | $439,808.28 | 75,677 |
| 08/05/2022 | DDS | 3,044 | Direct | COM | $609.62 | $1,855,683.28 | 72,023 |
| 08/05/2022 | DDS | 610 | Direct | COM | $608.70 | $371,307.00 | 75,067 |
| 08/05/2022 | DDS | 502 | Direct | COM | $619.64 | $311,059.28 | 53,072 |
| 1 2 3 4 5 6 7 8 9 10 Next Last You are at page 1 of 10 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research